Detection of actionable lung nodules and lung cancer Cancer
Conditions
Interventions
This is a pre-and post-deployment study. The study is observational at the patient level with no protocol-mandated procedures. A patient identified with a nodule will undergo management as per estab
Sponsors
Qure.ai Technologies Limited
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All participants above the age of 35 years obtaining chest X-rays at the site
Exclusion criteria
Exclusion criteria: Patients less than 35 years old and patients with known lung cancer at the time of chest X-ray
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The following primary outcome measures are assessed using data collected from the Qure AI qXR LN v4.0 device: 1. Difference in actionable pulmonary nodule detection rate on chest X-rays between pre- and post-deployment periods 2. Difference in proportion of lung cancer cases diagnosed through nodule pathway between pre- and post-deployment periods | — |
Secondary
| Measure | Time frame |
|---|---|
| The difference in the proportion of early-stage lung cancer among all lung cancer between pre and post-deployment periods assessed using data collected from the Qure AI qXR LN v4.0 device | — |
Countries
Netherlands
Contacts
Public ContactJacob J. Visser
Outcome results
None listed